AI-generated summary
The authors studied oral squamous cell carcinoma cells in culture, first treating them with 635 or 830 nm light at several doses. They report that this photobiomodulation pre-treatment increased ALA-induced PpIX accumulation and was associated with a greater cell-killing response to photodynamic therapy than PDT alone. The work was done only in cell culture, so the results may not apply to patients.
- Who or what was studied
- Oral squamous cell carcinoma cells in cell culture
- Wavelengths
- 635, 830 nm
- Limits stated in the abstract
- The study was performed only in cell culture, so the findings have not been tested in animals or people.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 830 nm, 635 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Photodynamic therapy, Fluence, Irradiance, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.